Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(60.0%)
N/A
2(40.0%)
5Total
Phase 4(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01960361Phase 4Completed

A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant

Role: lead

NCT02384291Not ApplicableUnknown

Sinus Floor Elevation Using Alpha-Bio's GRAFT Natural Bovine Bone vs. Commercially Available Bone Graft

Role: lead

NCT02897193Phase 4Unknown

Central Incisors Narrow Implants in Alternative to Bone Augmentation With 4.2 mm Implants .

Role: lead

NCT03854162Not ApplicableCompleted

A Study of a Surgical Guide for Dental Implantology

Role: collaborator

NCT02367261Phase 4Completed

A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant

Role: lead

All 5 trials loaded